| Secondary prevention of coronary artery disease. | |
| | |
MedLine Citation:
|
PMID: 20112887 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Coronary artery disease is the leading cause of mortality in the United States. In patients who have had a myocardial infarction or revascularization procedure, secondary prevention of coronary artery disease by comprehensive risk factor modification reduces mortality, decreases subsequent cardiac events, and improves quality of life. Options for secondary prevention include medical therapy and surgical revascularization in the form of coronary artery bypass grafting or percutaneous coronary intervention. Medical therapy focuses on comprehensive risk factor modification. Therapeutic lifestyle changes (including weight management, physical activity, tobacco cessation, and dietary modification) improve cardiac risk factors and are universally recommended by evidence-based guidelines. Treatment of hypertension and dyslipidemia reduces morbidity and mortality. Recommendations for persons with diabetes mellitus generally encourage glucose control, but current evidence has not shown reductions in mortality with intensive glucose management. Aspirin, angiotensin-converting enzyme inhibitors, and beta blockers reduce recurrent cardiac events in patients after myocardial infarction. Surgical revascularization by coronary artery bypass grafting is recommended for those with significant left main coronary artery stenosis, significant stenosis of the proximal left anterior descending artery, multivessel coronary disease, or disabling angina. Percutaneous coronary intervention may be considered in select patients with objective evidence of ischemia demonstrated by noninvasive testing. |
| | |
Authors:
|
Scott L Hall; Todd Lorenc |
Related Documents
:
|
22100927 - Computed tomographic angiography in tetralogy of fallot. 17236987 - Correlation between intramammary arterial calcifications and cad. 21873907 - Dynamic evaluation of a quadricuspid aortic valve with coronary computed tomography ang... 10086577 - Reminiscences of vasilii i. kolesov. 11174777 - Tibial bypass for limb salvage using polytetrafluoroethylene and a distal vein patch. 9170567 - Ex vivo surgery for renal artery aneurysms. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: American family physician Volume: 81 ISSN: 1532-0650 ISO Abbreviation: Am Fam Physician Publication Date: 2010 Feb |
Date Detail:
|
Created Date: 2010-02-01 Completed Date: 2010-02-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 1272646 Medline TA: Am Fam Physician Country: United States |
Other Details:
|
Languages: eng Pagination: 289-96 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright (c) 2010 American Academy of Family Physicians. |
Affiliation:
|
University of Nevada School of Medicine, Reno, NV 89557, USA. shallmd@specialtyhealth.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use Angiotensin-Converting Enzyme Inhibitors / therapeutic use Anticholesteremic Agents / therapeutic use Coronary Artery Disease / prevention & control* Depression / prevention & control Diabetes Mellitus / prevention & control Diet Exercise Humans Hypertension / prevention & control Platelet Aggregation Inhibitors / therapeutic use Risk Factors Risk Reduction Behavior Tobacco Use Cessation Weight Loss |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Anticholesteremic Agents; 0/Platelet Aggregation Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Biosurfactant production in sugar beet molasses by some Pseudomonas spp.
Next Document: FDA boxed warnings: how to prescribe drugs safely.